Loading clinical trials...
Loading clinical trials...
The study evaluates the efficacy and safety of SM-13496 compared with placebo in patients with Bipolar I Depression.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sumitomo Pharma Co., Ltd.
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT06370988 · Bipolar Depression, Bipolar Disorder, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT06488573 · Bipolar Depression, Bipolar Disorder (BD)
NCT06524505 · Bipolar Depression
Japan 76 sites
Tokyo
Lithuania 3 sites
Kaunas
Malaysia 5 sites
Kuala Lumpur
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions